Gait after Birmingham Hip Resurfacing: an age-matched controlled prospective study.

Journal: The Bone & Joint Journal
Treatment Used: Hip Resurfacing Arthroplasty (HRA)
Number of Patients: 28
Published:
MediFind Summary

Summary: In this study, researchers evaluated the effects of performing hip resurfacing arthroplasty (HRA) on hips which cause walking disturbances.

Conclusion: They found that after hip resurfacing arthroplasty, the patients walked as normally as persons without hip conditions.

Abstract

Aims: The aim of this study was to assess the functional gain achieved following hip resurfacing arthroplasty (HRA). Patients and

Methods: A total of 28 patients (23 male, five female; mean age, 56 years (25 to 73)) awaiting Birmingham HRA volunteered for this prospective gait study, with an age-matched control group of 26 healthy adults (16 male, ten female; mean age, 56 years (33 to 84)). The Oxford Hip Score (OHS) and gait analysis using an instrumented treadmill were used preoperatively and more than two years postoperatively to measure the functional change attributable to the intervention.

Results: The mean OHS improved significantly from 27 to 46 points (p < 0.001) at a mean of 29 months (12 to 60) after HRA. The mean metal ion levels at a mean 32 months (13 to 60) postoperatively were 1.71 (0.77 to 4.83) µg/l (ppb) and 1.77 (0.68 to 4.16) µg/l (ppb) for cobalt and chromium, respectively. When compared with healthy controls, preoperative patients overloaded the contralateral good hip, limping significantly. After HRA, patients walked at high speeds, with symmetrical gait, statistically indistinguishable from healthy controls over almost all characteristics. The control group could only be distinguished by an increased push-off force at higher speeds, which may reflect the operative approach.

Conclusion: Patients undergoing HRA improved their preoperative gait pattern of a significant limp to a symmetrical gait at high speeds and on inclines, almost indistinguishable from normal controls. HRA with an approved device offers substantial functional gains, almost indistinguishable from healthy controls. Cite this article: Bone Joint J 2019;101-B:1423-1430.

Authors
Anatole Wiik, Rhiannon Lambkin, Justin Cobb

Similar Latest Advances